Wire · technology
Roche Adds Molecular Testing Capacity in Democratic Republic of Congo Amid Ebola Outbreak
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 11 October 2026 · Fusion42 review
Roche Diagnostics has expanded molecular testing capacity in the Democratic Republic of Congo by supplying two molecular testing instruments and training local laboratory staff to validate a PCR test for the Bundibugyo virus amid an ongoing Ebola outbreak. This initiative supports local validation and capacity building critical to outbreak response.
This Wire brief sits within Fusion42's coverage of Health.
◆ ◆ The Wire takeaway
You can now access faster molecular testing for Bundibugyo virus in DRC, turning urgent outbreak response into a chance to build trusted local lab expertise and testing capacity. Equip your network with these validated PCR tools to reach cases before outbreaks intensify.
◆ Coverage
1 source · 7 Oct 2026
◆ Related on Wire
◆ Topics